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httense.Abstract Background: Diabetic peripheral neuropathy (DPN) is a worldwide costly complication
of diabetes.
Objective: To evaluate the relationship between the sonographically measured cross-sectional area
(CSA) of the median nerve and nerve conduction study (NCS) in children with type1 diabetes
(T1DM) complaining of DPN.
Material and methods: Forty childrenwithT1DMand20age-matchedhealthy subjectswere enrolled
in this study.Thediabetic childrenweredivided into2groups (without andwithDPN).All participants
underwent NCS and sonographic measurement of CSA for the median nerve in the carpal tunnel.
Results: TheCSA of themedian nerve in children withDPNwas higher than that in the control subjects
yetwithnosigniﬁcantdifferencewiththatofchildrenwithoutDPN.TheincreasedmediannerveCSAinthe
carpal tunnel was considerably correlated with the median nerve motor latency and duration of diabetes,
nevertheless, with no correlation with median nerve motor conduction velocity (MNCV).
Conclusion: Sonographic measurement of CSA of the median nerve in the carpal tunnel serves as a good
discriminator for diabetic children from healthy individuals. Moreover, it has signiﬁcant positive correla-
tion with duration of disease and the nerve motor latency.
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The World Health Organization estimates that more than 220
million people worldwide have diabetes mellitus (DM) (1).
Furthermore, International Diabetes Federation states 78,000
children develop T1DM every year (2).
Diabetic neuropathy is recognized as the most common
clinical picture of nervous system disorders caused by DM
(3) and is considered the most common type of neuropathies.
It affects patients with both type1 and type2 diabetes, but it
progresses more rapidly and its manifestations are more severe
in T1DM (4). Earlier observations and population-based co-
hort studies have shown that 66% of patients who have
T1DM develop some form of neuropathy (5).
For the evaluation of peripheral neuropathy (PN), physi-
cians traditionally relied primarily on information gained from
an accurate clinical history, a thorough physical examination
and electrodiagnostic testing with NCS (6,7). However, such
diagnostic tests and studies do not provide spatial information
regarding the nerve and the surrounding structures (8). Ultra-
sonography (US) provides a rapid, cheap and non invasive
method for the examination of the soft tissue structures of
the wrist as it easily detects the median nerve which is located
deep to the retinaculum (9).
A sophisticated search revealed a limited knowledge of dia-
betic peripheral neuropathy (DPN) in children and a largely
variable reported prevalence of PN in different studies of pedi-
atric patients with T1DM. Moreover, these children are more
prone to complications because of the early onset of diabetes
and accordingly, to assure them of a better life style through
early detection and proper management of the complications
of the PN.
Thus, our hypothesis is to demonstrate the relationship be-
tween the sonographically measured CSA of the median nerve
in children with T1DM complaining of DPN and the results of
NCS.
2. Materials and methods
We conducted the study on 40 eligible consecutive patients
with type1 diabetes [10 males, 30 females (mean age
15.2 ± 2.9 years; range: 7–18 years)] recruited from the regular
attendants of the Pediatric Diabetes Clinic, Children’s Hospi-
tal between June 2011 and January 2012. These patients were
included in the order that they showed up in the diabetes clinic.
To be eligible for the study patients had to satisfy the fol-
lowing criteria: (1) children with T1DM, who are able to per-
form all neurological examinations and tests and (2) having
diabetes for more than ﬁve years. We divided the diabetic chil-
dren into 2 groups; children with and without diabetic periph-
eral neuropathy (DPN). DPN was diagnosed on the basis of
sensory symptoms in the form of bilateral tingling and numb-
ness which started a few months ago. Complete history taking
was performed including age, diabetes duration, complications
and insulin regimen for the 40 diabetic patients.
Full clinical neurological examination was done to conﬁrm
peripheral neuropathy if present. We adopted the simple rapid
bedside neuropathy disability score (NDS) as a screening tool
for DPN (10). The NDS was derived from the examination of
vibration perception (by means of a 128-Hz tuning fork), pin-
prick and temperature perceptions in the great toe and thepresence or absence of ankle reﬂexes. The sensory modalities
were scored as either present (0) or reduced or absent (1) for
each leg. This means that ‘‘reduced’’ was scored as (1) indicat-
ing involvement of the nerve. Ankle reﬂexes were scored as
normal (0), present with reinforcement (1) or absent (2) for
each leg. The total maximal abnormal score was 10. A score
above 2 was deﬁned as clinical DPN (11).
Exclusion of neuropathies other than DPN was considered.
This includes the following: patients with other signiﬁcant
chronic diseases (renal, liver and thyroid diseases) and other
systemic diseases that affect the central nervous system. In
addition, history of familial neuropathy, other neurological
diseases, alcohol consumption, medications and exposure to
toxins (known to cause neuropathy), patients with mental
retardation or psychiatric diseases were excluded. Anthropo-
metric measures; weight in kg, height in cm and body mass in-
dex (BMI); were calculated as weight in kilograms divided by
square of height in meters, which were measured and recorded.
Other microvascular complications were screened including
diabetic retinopathy (DR) that was diagnosed by doing com-
plete ocular examination and indirect ophthalmoscopy. Fur-
ther urinary albumin excretion was measured by the
immuno-turbidimetric method for the detection of diabetic
nephropathy. The kit used was from SERA-PAK (Bayer Cor-
poration, Bendict Ave., Tarrytown, NY, USA). The result was
expressed as albumin to creatinine ratio (ACR) in urine to
avoid diurnal variation in albumin excretion. Urinary creati-
nine was estimated on Synchron C·7 (Beckman Instruments
Inc., Brea., CA, USA). Venous blood samples were obtained
in the morning from all patients after an overnight fast. A
2 ml blood sample was drawn from peripheral veins under
complete aseptic conditions. The tube was placed on EDTA
for the direct assay of HbA1c. The average of HbA1c measure-
ments was determined and calculated for each patient (four
determinations per year) with an average length of three
months between each HbA1c measurement.
For comparison, we enrolled 20 age-matched healthy sub-
jects (12 males and 8 females) with no obvious medical disor-
der and not receiving any medication who served as a control
group. This group included children recruited from the same
region as the case subjects; most were classmates or acquain-
tances of the case subjects. They were age–BMI – matched
healthy individuals with a mean age of 13.9 ± 3.3 years; range:
7–17 years. We studied a total of 120 upper limbs in all 60 sub-
jects who underwent median NCS and sonographic measure-
ment of the median nerve CSA about 5 cm proximal to the
wrist (in the carpal tunnel). These investigations were done
concurrently in the same day.
The study protocol was approved by the Committee of Eth-
ics and the parents of all study participants; the patients and
the control subjects gave their written informed consent.2.1. Sonographic measurement of the median nerve cross-
sectional area (CSA)
Sonographic examination was performed unbiased to patient’s
history and NCS results using a Philips HD11 Revision 1.0.9
imaging system with an L12-3 linear array probe and a B mode
real time apparatus. The examiners had a board-certiﬁed
license and more than 10 years of experience. Patients were
seated in a chair with arms extended, hands resting in a
Fig. 1b Normal sonographic appearance of transverse scan of
the median nerve (MN) in the wrist of a child of the control group;
showing multiple hypoechoic bands corresponding to neuronal
fascicles which are separated by hyperechoic lines that correspond
to the epineurium.
Fig. 1c Normal transverse scan of the median nerve (MN) in the
wrist of a child of the control group; showing its normal elliptic
outline.
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ﬁngers semiextended (12). We performed longitudinal
(Fig. 1a) and transverse scans of the median nerve about
5 cm proximal to the wrist (in the carpal tunnel).
We traced the median nerve through its course as follows. It
crosses superﬁcially to the brachial artery at the mid-humerus
to lie on its medial side. The nerve enters the forearm between
the heads of pronator teres, the deeper of which separates it
from the ulnar artery, while, at the wrist, the median nerve be-
comes superﬁcial on the ulnar side of ﬂexor carpi radialis, ex-
actly in the midline (13). Accordingly, advanced sonographic
techniques such as color Doppler and power Doppler imaging
were used in this study in order to identify the median nerve in
children with poor sonographic images.
The normal appearance of the peripheral nerve should be
readily recognized as it consists of multiple hypoechoic bands
corresponding to neuronal fascicles, which are separated by
hyperechoic lines that correspond to the epineurium
(Fig. 1b) (14). The median nerve lies within the carpal tunnel
just to the radial side of the superﬁcial row of ﬂexor digitorum
tendons. On transverse sonograms, the nerve appears elliptic in
outline (Fig. 1c) (9).
We measured median nerve CSA at the inner border of the
thin hyperechoic rim of the nerve (perineurium) using the man-
ual tracing technique (Fig. 1d) as according to Hammer et al.
(15), this method of measurement of median nerve CSA yields
the most correct CSA. The weight of the probe was also ap-
plied without additional pressure.Fig. 1d Measurement of the median nerve (MN) CSA in the
wrist at the inner border of the thin hyperechoic rim of the nerve
(perineurium) using the manual tracing technique in a child of the
control group being 0.039 cm2.2.2. Nerve conduction study
The nerve conduction study was performed with conventional
procedure using the Schwarzer Topaz machine, Germany.
NCS was done on both median nerves measuring the motor
nerve conduction velocity (MNCV) and the motor latency
from the elbow to the wrist joint in a room with ambient tem-
perature of 25 C and skin surface temperature between 31 C
and 33 C. The pick up (active) electrode was placed on the
prominence of abductor pollicis brevis muscle. The reference
was placed on the distal phalanx of the thumb. The ground
electrode was placed between the active and the stimulator.
The distal stimulation was applied 8 cm proximal to the active
electrode and is placed between the ﬂexor carpi radialis and
palmaris longus tendons. The proximal stimulation was ap-
plied in the medial aspect of the antecubital fossa just lateral
to the brachial artery.Fig. 1a Normal sonographic appearance of longitudinal scan of
the median nerve (MN) in the wrist of a child of the control group.2.3. Statistical analysis
SPSS statistics (V. 19.0, IBM Corp., USA, 2010) was used for
data analysis. Data were expressed as Mean ± SD for quanti-
tative parametric measures and both number and percentage
for categorized data. For comparison between two indepen-
dent mean groups for parametric data, Student’s t test was
used, while, Wilcoxon Rank Sum test was used for comparison
between two independent groups for non-parametric data.
Additionally, Ranked Spearman’s correlation test was applied
to study the possible association between each of the two vari-
ables among each group for non-parametric data. Chi-square
test was applied, as well, to study the association between each
of the two variables or comparison between two independent
groups as regards the categorized data.
The probability of error (p value) at 0.05 was considered
signiﬁcant, while, at 0.01 and 0.001 was considered highly
signiﬁcant. To obtain the most sensitive and speciﬁc cut-off
value for the sonographically measured CSA of the median
566 R. Refaat et al.nerve, Diagnostic Validity Test was used and ROC was
constructed. AUC was calculated to evaluate the most discrim-
inating markers between the compared groups.
3. Results
Demographic data for the diabetic children and the control
individuals were recorded as shown in Table 1. There were
no signiﬁcant differences in age, height, weight and BMI be-
tween the diabetic children and the healthy subjects.
Patients with type1 diabetes were 10 males and 30 females.
It is not surprising that in this series, there is a predominance
of females (75%) in T1DM cohort. It was previously reported
that unlike many other autoimmune diseases, where females
are more at risk of disease, T1DM subgroups have a similar
gender distribution when diagnosed under age 15 with
T1DM. However, a minor male excess in incidence has been
reported in Europe and in populations of European origin
and as light female excess in populations of African or Asian
origin (16).
The included patients used human insulin in a dose ranging
from 0.5 to 2.5 IU/kg/day with a mean of 1.8 ± 0.38 IU/kg/
day; all of them were on intensive insulin therapy. 28 patients
were on preprandial injections of short-acting insulin and
intermediate acting insulin (isophane NPH insulin) and 12 pa-
tients were on long acting insulin analog (insulin glargine –
Aventis Pharma) at bedtime and preprandial short acting insu-
lin analog. Of the 40 patients who were enrolled in the study,
13 patients (32.5%) exhibited diabetic nephropathy in the form
of microalbuminuria with a mean range of 90 ± 57.4 (mg/l)
and none had macroalbuminuria. 4 patients had both
nephropathy and peripheral neuropathy (10%). None of the
enrolled patients had diabetic retinopathy.
By using Pearson Chi-Square test, there was a signiﬁcant
difference (p= 0.024) between ratio of females to males in
children without and with diabetic peripheral neuropathy
(DPN). Children without DPN group comprised of 14 females
(70%) and 6 males (30%) and children with DPN group com-
prised of 16 females (80%) and 4 males (20%), while, control
individuals comprised of 8 females (40%) and 12 males (60%).
The sonographically measured CSA and the NCS results
for the diabetic children and the healthy subjects are shown
in Table 2.
Comparison between control individuals versus children
without DPN, control individuals versus children with DPN
and children without DPN versus children with DPN concern-
ing the mean value of median nerve CSA, the mean value of
median nerve motor latency and the mean value of medianTable 1 Detailed demographic data of the study subjects.
Variable Control individuals
n 20
Sex, male/female 12/8
Age, y ± SD 13.9 ± 3.3
Height, cm ± SD 158 ± 6.5
Weight, kg ± SD 55.2 ± 11.2
Body mass index ± SD 20.1 ± 2.7
Duration of diabetes, y ± SD NA
NA, not applicable; SD, standard deviation.nerve motor nerve conduction velocity (MNCV) were done.
The results are summarized in Table 3 according to the value
of the probability of error (p value) to express the signiﬁcance
of the difference between the compared groups.
The mean median nerve CSA in the control individuals
showed statistically highly signiﬁcant difference (p= 0) com-
pared to that of children without (Fig. 2) and with DPN
(Fig. 3) as it was 0.043 versus 0.072 cm2 and 0.073 cm2 respec-
tively. There was no statistical signiﬁcance (p= 0.828) be-
tween mean median nerve CSA of children without DPN
and that of children with DPN being 0.072 cm2 versus
0.073 cm2.
The mean value of median nerve motor latency in the con-
trol individuals showed statistically highly signiﬁcant differ-
ence compared to that of children without (p= 0.001) and
with DPN (p= 0.005) as it was 2.96 ms versus 3.4 ms and
3.5 ms respectively. There was no statistical signiﬁcance
(p= 0.747) between the mean value of median nerve motor la-
tency of children without DPN and that of children with DPN
being 3.4 ms versus 3.5 ms.
The mean value of median nerve MNCV in the control
individuals showed statistically no signiﬁcant difference
(p= 0.085) compared to that of children without DPN and
statistically signiﬁcant difference (p= 0.016) compared to that
of children with DPN as it was 54.6 m/s versus 52.9 m/s and
54.6 m/s versus 51.5 m/s respectively. There was no statistical
signiﬁcance (p= 0.312) between the mean value of median
nerve MNCV of children without DPN and that of children
with DPN being 52.9 m/s versus 51.5 m/s.
There was a non signiﬁcant difference between children
without DPN (p= 0.14) and those with DPN (p= 0.549)
regarding the mean value of HbA1c and duration of diabetes,
yet the values of HbA1c were higher in children with DPN.
In the group of children without DPN, the mean median
nerve motor latency for both wrists had no correlation with
duration of diabetes (r= 0.327; p= 0.159) and HbA1c
(r= 0.148; p= 0.534). The mean median nerve MNCV for
both wrists had no correlation with duration of diabetes
(r= 0.375; p= 0.103) and a highly signiﬁcant negative cor-
relation with HbA1c (r= 0.626; p= 0.003). The mean med-
ian nerve CSA for both wrists had no correlation with
duration of diabetes (r= 0.111; p= 0.642) and no correla-
tion with HbA1c (r= 0.399; p= 0.082).
In the group of children with DPN, the mean median nerve
motor latency for both wrists had no correlation with the dura-
tion of diabetes (r= 0.163; p= 0.494) and HbA1c (r= 0;
p= 1). The mean median nerve MNCV for both wrists had
a highly signiﬁcant negative correlation with duration of dia-Children without DPN Children with DPN
20 20
6/14 4/16
15.9 ± 2.7 14.6 ± 3.5
162 ± 4.5 151.5 ± 8.8
63.2 ± 9.2 50.4 ± 18.8
24 ± 3.2 21.7 ± 7.2
8.6 ± 3.8 8.5 ± 3.7
Table 2 Sonographically measured CSA and NCS results in the study subjects.
Parameter Control individuals Children without DPN Children with DPN
Mean sonographically measured CSA, cm2 ± SD 0.043 ± 0.016 0.072 ± 0.021 0.073 ± 0.0175
Electrophysiologic measurement of mean motor latency, ms ± SD 2.96 ± 0.45 3.4 ± 0.50 3.5 ± 0.47
Electrophysiologic measurement of mean MNCV, m/s ± SD 54.6 ± 1.8 52.9 ± 3.8 51.5 ± 5.06
Table 3 Comparison between control individuals, children without DPN and children with DPN concerning the mean value of
median nerve CSA, the mean value of median nerve motor latency and the mean value of median nerve MNCV.
Parameter The mean value of
median nerve CSA
The mean value of median
nerve motor latency
The mean value of
median nerve MNCV
Control individuals versus
children without DPN
HS (p= 0) HS (p= 0.001) NS (p= 0.085)
Control individuals versus
children with DPN
HS (p= 0) HS (p= 0.005) S (p= 0.016)
Children without DPN versus
children with DPN
NS (p= 0.828) NS (p= 0.747) NS (p= 0.312)
HS, highly signiﬁcant; S, signiﬁcant; NS, non signiﬁcant.
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p= 0). The mean median nerve CSA for both wrists had no
correlation with HbA1c (r=  0.438; p= 0.054) and a signif-
icant positive correlation with the duration of diabetes
(r= 0.46; p= 0.041).
In the group of the control individuals, the mean median
nerve CSA for both wrists had no correlation with mean med-
ian nerve MNCV for both wrists (r= 0.176; p= 0.457) and
a highly signiﬁcant positive correlation with mean median
nerve motor latency for both wrists (r= 0.778; p= 0).
In the group of children without DPN, the mean median
nerve CSA for both wrists had no correlation with mean med-
ian nerve motor latency for both wrists (r= 0.17; p= 0.473)
and with mean median MNCV for both wrists (r= 0.358;
p= 0.122).
In the group of children with DPN, the mean median nerve
CSA for both wrists had a highly signiﬁcant positive correla-
tion with median nerve motor latency for both wrists
(r= 0.735; p= 0) (Fig. 4) and no correlation with mean med-
ian MNCV for both wrists (r= 0.079; p= 0.741).
We found that the best cut-off value of the sonographically
measured median nerve CSA between control individuals and
children without DPN is 0.0435 (0.044) (Fig. 5) (i.e. >(0.044)
identify children without DPN & <(0.044) identify control
individuals with sensitivity = 100%, speciﬁcity = 70%, posi-
tive predictive value = 76.9%, negative predictive va-
lue = 100% and efﬁcacy or diagnostic accuracy = 85%.
We found that the best cut-off value of the sonographically
measuredmedian nerveCSA for discrimination between control
individuals and children with DPN is 0.0455 (0.046) (Fig. 6) (i.e.
>(0.046) identify children with DPN and <(0.046) identify
control individuals with sensitivity = 100%, speciﬁc-
ity = 80%, positive predictive value = 83.3%, negative predic-
tive value = 100% and efﬁcacy or diagnostic accuracy = 90%.
Additionally, we found that the best cut-off value of the
mean median nerve motor latency of both wrists between con-
trol individuals and diabetic children whether without or withDPN is 3 (i.e. >3) identify diabetic children (without DPN or
with DPN) and <(3) identify control individuals with sensitiv-
ity = 80%, speciﬁcity = 70%, positive predictive va-
lue = 72.7%, negative predictive value = 77.8% and efﬁcacy
or diagnostic accuracy = 75%.
In our study, no cut-off value was found regarding the
mean median nerve CSA of both wrists and the mean median
nerve motor latency of both wrists for discrimination between
diabetic children without and with DPN. Moreover, we did
not ﬁnd any cut-off value regarding the mean median nerve
MNCV of both wrists for discrimination between control
individuals and diabetic children whether without or with
DPN nor between diabetic children without and with DPN.
These are because no statistically signiﬁcant difference was
found between the compared groups regarding the previously
mentioned parameters.4. Discussion
Between 2010 and 2030, there will be a 69% increase in the
number of adults (aged 20–79 years) with diabetes in develop-
ing countries and a 20% increase in developed countries. These
predictions indicate a growing burden of diabetes, particularly
in developing countries. Also, the prevalence of diabetes ad-
justed to national population in Egypt in 2010 is 10.4% and
expected to be 12.8% in 2030. Additionally, estimated diabetes
numbers among adults aged 20–79 years will be changed from
4.787 million in 2010 to 8.615 million in 2030 with a mean an-
nual increment of 191 (17).
Diabetic peripheral neuropathy (DPN) is a common, dis-
abling and costly complication of diabetes mellitus (18). The
prevalence of diabetic neuropathy also increases with time
and poor glycemic control (19–21) and severe diabetic poly-
neuropathy can develop in young adults within a few months
after the onset of T1DM if the diabetes is poorly controlled
(22).
Fig. 2 The median nerve (MN) CSA in a child without DPN: (A) Transverse scan of the median nerve in the wrist showing the neuronal
fascicles and the epineurium. (B) The sonographically measured CSA at the inner border of the perineurium using the manual tracing
technique was 0.071 cm2.
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thy have a distal symmetrical form of the disorder (23,24). In
this neuropathic pattern, signs and symptoms start and remain
more pronounced in the feet and go on to affect more proximal
parts of the lower limbs and eventually the distal parts of the
upper limbs (25).
The diagnosis of diabetic neuropathy is based on its charac-
teristic symptoms and can be conﬁrmed with NCS (5,26–28).
Although, NCS is generally considered to be the most sensitive
for detecting and monitoring DPN, its utilization in patients
with diabetes is low (18). This is presumably because the
NCS is time-consuming, slightly invasive and generally not
well tolerated for repeated evaluations (29).
Sonographic examinations can be performed to assess
peripheral nerves and have already been used for the evalua-
tion of disorders of the peripheral nervous system (30–36). Ad-
vances in ultrasound technology have made it possible to
achieve a good spatial resolution for clear evaluation of the
peripheral nerves. Wide availability, low cost, non invasive-
ness, being painless and short examination time are the advan-
tages of sonography (37). Though, US is operator dependent,
it shows high reproducibility after adequate training of the
operators (38).
As sonography is a non invasive method, it can be used
for the measurement of the nerve CSA providing important
additional information in patients with suspected neuropa-
thy. Sonographic measurements of the nerve CSA includetwo methods: the indirect method (ellipsoid formula) (CSA
(mm2) = major axis · minor axis · p · l/4) and the direct
method (tracing) (36). Recently, Alema`n et al. (39) reported
that sonography for median nerve CSA measurements were
reproducible either by tracing or by indirect method when a
standardized sonographic examination protocol was used.
We used the direct method (tracing) for the examination
and measured it about 5 cm from the wrist (in the carpal
tunnel).
The mechanism of diabetic neuropathy involves the patho-
genesis of damage to the pain mechanism, which is multifacto-
rial and includes metabolic disturbances such as
hyperglycemia, even impaired glucose tolerance, dyslipidemia,
oxidative and nitrosative stress, growth factor deﬁciencies,
microvascular insufﬁciency and autoimmune damage to nerve
ﬁbers (40).
It has been also reported that abnormalities in diabetic neu-
ropathy include axonal degeneration in nerve ﬁbers and pri-
mary demyelination resulting from Schwann cell dysfunction
(41). Suzuki et al. (42) reported that sorbitol itself and second-
ary sodium accumulation caused by an increase in sorbitol
may have been major contributors to the increase in intracellu-
lar hydration in a hydrogen 1 nuclear magnetic resonance
study. It has further been hypothesized that in individuals with
diabetes mellitus, the peripheral nerve is swollen because of in-
creased water content related to increased aldose reductase
conversion of glucose to sorbitol (43).
Fig. 3 The median nerve (MN) CSA in a child with DPN: (A) Transverse scan of the median nerve in the wrist showing the neuronal
fascicles and the epineurium. (B) The sonographically measured CSA at the inner border of the perineurium using the manual tracing
technique was 0.103 cm2.
Fig. 4 Linear Regression analysis showing a highly signiﬁcant
positive correlation between the mean CSA of the median nerve
and the mean median nerve motor latency among children with
DPN(r= 0.735; p= 0).
Fig. 5 ROC curve analysis showing the diagnostic performance
of the mean CSA for discriminating patients without DPN from
control individuals, AUC= 0.814.
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the soles or feet and the wide use of NCS in the diagnosis of
DPN making NCS in the lower limbs to appear more appro-
priate for assessing DPN, we performed NCS in the upper
limbs. This is because NCS in the lower limbs is lengthy and
action potentials in the lower limbs sometimes cannot be
evoked in patients with advanced DPN. Moreover, Sasaki
et al. (44) and Kohara et al. (45) reported that motor nerve
conduction velocity (MNCV) slowing in the upper limbs was
similar to that in the lower limbs of diabetic patients. Also,the skin temperature and humidity easily affect the sensory
nerve conduction velocity at the time of measurement, so it
is often impossible to measure (36).
Mizumoto et al. (46) chose to look at the distal motor la-
tency and MNCV because the sensory nerve conduction veloc-
ity was not measurable in many hands and therefore appeared
to be an unsuitable parameter. Thus, we carried out motor
nerve conduction studies only in the upper limbs. This is also
sustained as small myelinated and unmyelinated nerve ﬁbers,
Fig. 6 ROC curve analysis showing the diagnostic performance
of the mean CSA for discriminating patients with DPN from
control individuals, AUC= 0.844.
570 R. Refaat et al.which are affected early in the disease course of diabetic neu-
ropathy; do not contribute to the sensory action potential de-
tected by routine NCS. The sensory action potential is altered
only after involvement of larger myelinated ﬁbers, which is of-
ten a late event in patients with diabetes (41).
The mean median nerve CSA in our study was signiﬁcantly
larger in diabetic children without and with DPN compared
with that of control individuals, but there was no signiﬁcant
difference between diabetic children without and with DPN.
Alternatively, Watanabe et al. (36) established in their study
that the CSA was signiﬁcantly larger in patients with DPN
than in the control individuals and patients without DPN.
Our results showed that the increase in the sonographically
measured cross-sectional area of the median nerve was accom-
panied with diminished MNCV and delayed motor latency.
This ﬁnding goes in agreement with the results of the study
done by Watanabe et al. (36). We also coincide with Watanabe
et al. (36) who did not only hypothesize that an enlarged med-
ian nerve in diabetic patients may occur because of increased
water content but also suggested that the nerve swelling due
to increased water content may partly contribute to slowing
of the nerve conduction. Additionally, it was found that there
is slowing of nerve conduction velocity in symptomatic dia-
betic neuropathy owing to demyelination and loss of large
myelinated ﬁbers and a decrease in nerve action potentials ow-
ing to loss of axons (47–49).
We also found in the group of children without DPN that
the mean median nerve CSA for both wrists had no correlation
with mean median nerve motor latency for both wrists and a
signiﬁcant negative correlation with mean median nerve
MNCV. While, in the group of children with DPN, the mean
median nerve CSA for both wrists had a highly signiﬁcant po-
sitive correlation with mean median nerve motor latency for
both wrists and no correlation with mean median MNCV. In-
stead of that, Watanabe et al. (36) ascertained through their
study that the CSA had a signiﬁcant positive correlation with
the motor latency as well as a signiﬁcant negative correlation
with the MNCV.
In this study, there was signiﬁcant difference regarding the
mean median nerve MNCV between control individuals versuschildren with DPN, This concurs with Riihimaa et al. (50) who
stated that deterioration in nerve segmental myelination and
axonal structure, reﬂected in decreased nerve conduction
velocity, has been implicated as contributing to the peripheral
nerve problems seen in patients with type1 diabetes. Moreover,
Dyck (51) declared that accumulation of sorbitol and fructose
generated from glucose shunted into the polyol pathway by al-
dose reductase and sorbitol dehydrogenase together with deﬁ-
ciencies of myoinositol and diacylglycerol may all combine as
potent metabolic factors for slowed conduction velocity.
Even though, we found that there was a non signiﬁcant dif-
ference between children without DPN and those with DPN
regarding the mean value of HbA1c and the duration of diabe-
tes with the values of HbA1c being higher in children with
DPN. Conversely, Cenesiz et al. (52) concluded that the dura-
tion of disease and impaired glycemic control play an impor-
tant role in the development of neuropathy. This was
accomplished through the statistically signiﬁcant relationships
which were found between the glycemic control values and the
duration of disease with the median nerve conduction velocity.
Also, Lee et al. (53) recognized that the duration of diabetes
and poor glycemic control proved to be more important risk
factors over 5 years as related to the development of subclini-
cal neuropathy. Moreover, Oguejiofor et al. (54) accomplished
that diabetic subjects with a long duration of diabetes
(>10 years) almost always have associated peripheral neurop-
athy. In view of that, Said (41) stated there is currently no
effective treatment for diabetic neuropathy and good glycemic
control is the only way to minimize the risk of occurrence of
neuropathy in patients with diabetes.
Finally, we recommend further studies regarding this age
group with a much larger number of diabetic children to con-
ﬁrm our ﬁndings. Consequently, this will lead to early manage-
ment of complications of PN and hence a better way of life.
5. Conclusion
The sonographically measured CSA of the median nerve in the
carpal tunnel of children with DPN is greater than that of
healthy individuals correlating considerably with the median
nerve motor latency and in addition, it has signiﬁcant positive
correlation with the duration of diabetes.
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